Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat

Life Sciences

Volumn 63, Issue 3, 1998, Pages 155-160

  Holschneider, D P ^a,b   Kumazawa, T ^c   Chen, K ^a   Shih, J C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Brain; Estrogen; MAO A; MAO B; Tissues

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ESTRADIOL; ESTROGEN; PHENETHYLAMINE; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; HYPOTHALAMUS; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; RAT; TISSUE SPECIFICITY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; OVARIECTOMY; PLACEBOS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032511108     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00255-0     Document Type: Article

References (25)

1. 1. M.J. KATOVICH and J. O'MEARA, Can. J. Physiol. Pharmacol. 65 563-7 (1987).
2. 2. H.Z. KE, H.K. CHEN, H.A. SIMMONS, H. QI, D.T. CRAWFORD, C.M. PIRIE, K.L. CHIDSEY-FRINK, Y.F. MA, W.S. JEE and D.D. THOMPSON, Bone 20 31-9 (1997).
3. 3. V.N. LUINE, R.I. KHYLCHEVSKAYA and B.S. MCEWEN, J. Neurochem. 23 925-34 (1974).
4. 4. K. CHEN, H.F. WU, J. GRIMSBY and J.C. SHIH, Molec. Pharmacol. 46 1226-33 (1994).
5. 5. R.L. GOODMAN, Endocrinol. 102 142-50 (1978).
6. 6. D.P. HOLSCHNEIDER and O.U. SCREMIN, Neuroendocrinol. 167 in press (1998).
7. 7. G.G. COLLINS, J. PRYSE-DAVIES, M. SANDLER and J. SOUTHGATE, Nature 226 642-3 (1970).
8. 8. D.S. GROSSO and A.M. GAWIENOWSKI, J. Endocrinol. 65 207-14 (1975).
9. 9. M. HOLZBAUER and M.B. YOUDIM, Brit. J. Pharmacol. 48 600-8 (1973).
10. 10. I. DYNAROWICZ and T. WATKOWSKI, Archiv. Veterinar. Polonic. 33 29-37 (1993).
11. 11. V.N. LUINE and B.S. MCEWEN, J. Neurochem. 28 1221-7 (1977).
12. 12. B.G. ORTEGA-CORONA, A. VALENCIA-SANCHEZ, C. KUBLI-GARFIAS, F. ANTON-TAY, L.A. SALAZAR, J.E. VILLARREAL and H. PONCE-MONTER, Arch. Med. Res. 25 337-40 (1994).
13. 13. E.E. JONES and F. NAFTOLIN, Brain Res. 510 84-91 (1990).
14. 14. M. UNZETA, S. BARON, V. PEREZ, S. AMBROSIO and N. MAHY, Neurosci. Lett. 176 235-8 (1994).
15. 15. M. HOLZBAUER and M.B.H. YOUDIM, Proc. Brit. Pharmacol. Soc. 355P-356P.
16. 16. A.J. ZOLOVICK, R. PEARSE, K.W. BOEHLKE and B.E. ELEFTHERIOU, Science 154 649 (1966).
17. 17. I.A. KAMBERI and Y. KOBAYASHI, J. Neurochem. 17 261-8 (1970).
18. 18. M.M. SALSEDUC, I.J. JOFRE and J.A. IZQUIERDO, Med. Pharmacol. Exp. 14 113-9 (1966).
19. 19. M.S. SMITH, M.E. FREEMAN and J.D. NEILL, Endocrinol. 96 219-26 (1975).
20. 20. V.N. LUINE and C.M. PADEN, Neuroendocrinol. 34 245-51 (1982).
21. 21. M. NAKAYAMA, H. INAO, K. YAGI and M. MAEYAMA, Jap. Heart J. 19 563-4 (1978).
22. 22. E.V. MACKAY, S.K. KHOO and N.A. SHAH, Obstet. Gynecol Survey 28 155-65 (1973).
23. 23. Y.S. BAKHLE and R.R. BEN-HARARI, J. Physiol. 291 11-8 (1979).
24. 24. A.W. BACH, N.C. LAN, D.L. JOHNSON, C.W. ABELL, M.E. BEMBENEK, S.W. KWAN, P.H. SEEBURG and J.C. SHIH, Proc. Natl. Acad. Sci. USA 85 4934-8 (1988).
25. 25. Q.S. ZHU, J. GRIMSBY, K. CHEN and J.C. SHIH, J. Neurosci. 12 4437-46 (1992).